TARA Biosystems Biowire™ II Heart-on-a-Chip Platform Published in CELL
January 24, 2019
News
NEW YORK, N.Y. (Newswire.com)—January 24, 2019—TARA Biosystems, Inc., a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced the first peer-reviewed publication of its Biowire™ II platform by …
TARA Biosystems and Insilico Medicine Announce Drug Discovery Collaboration for Cardiac Disease
January 7, 2019
Featured
New York – TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and risk assessment applications and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases, announced today the launch of a collaboration to discover and develop novel therapies for …
TARA Launches Cardiotype.Fo, Best-In-Class Assay for Cardiac Contractility
September 27, 2018
News
New York, (Newswire.com) - TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and development applications announced today the launch of Cardiotype.Fo, the best-in-class in vitro system for assessment of cardiac …
Frost & Sullivan Recognizes TARA With 2018 North American Technology Innovation Award
September 25, 2018
News
TARA has received Frost & Sullivan’s 2018 North American Technology Innovation Award for our Biowire™ II platform! This award recognizes companies that develop innovative products with rapid market adoption. In addition, it is part of a broader set of Frost & Sullivan’s Best Practices awards presented to companies …
TARA CEO Misti Ushio Named to Fast Company's 100 Most Creative People in Business
May 30, 2018
Press Releases
New York, (Newswire.com) - TARA Biosystems is proud to announce that TARA CEO Dr. Misti Ushio has been recognized by Fast Company as one of the Top 100 Most Creative People in Business today. The annual list honors an …